Industry weighs radical shake-up of European drug pricing
Wholesale adoption of the concept of drug pricing based on clinical results is proposed
Sat, Jun 11, 2016 - 5:50 AM
PRICING MATTERS: Mr Jimenez, the current president of Efpia, supports the pricing concept.
THE pharmaceutical industry is considering a radical shift in the way it prices drugs in Europe so companies are rewarded for the clinical benefit of treatments rather than the number of pills sold, according to an internal report.